{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1040",
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.464.1003.110.12.1040"
  } ],
  "version": "20170504",
  "name": "VaricellaZosterVaccine(VZV)Administered",
  "title": "Varicella Zoster Vaccine (VZV) Administered",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "expansion": {
    "identifier": "20240502",
    "timestamp": "2025-01-10T13:55:23-07:00",
    "contains": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90710",
      "display": "Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90716",
      "display": "Varicella virus vaccine (VAR), live, for subcutaneous use"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "425897001",
      "display": "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "428502009",
      "display": "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "432636005",
      "display": "Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "433733003",
      "display": "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "572511000119105",
      "display": "Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "737081007",
      "display": "Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "871898007",
      "display": "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "871899004",
      "display": "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2023-09",
      "code": "871909005",
      "display": "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
    } ]
  }
}